Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

King Pharma, Pain Therapeutics change Remoxy deal
Yahoo/AP
Tuesday, June 29, 2010 - 9:13am
tags:
Pain Therapeutics, King, Remoxy, painkillers, Europe
Depomed receives $10 million milestone payment from partner Abbott Products for pain drug
Yahoo/AP
Tuesday, June 29, 2010 - 9:13am
tags:
Depomed, Abbott Laboratories, partnerships, shingles
Abbott looks to sell its flu vaccine unit: report
Reuters
Tuesday, June 29, 2010 - 9:11am
tags:
Abbott Laboratories, M&A, Flu, vaccines, Solvay
GSK backs Avandia again amid renewed pressure for withdrawal
Pharma Times, UK
Tuesday, June 29, 2010 - 9:08am
tags:
GSK, Avandia, diabetes
Why Avandia Will Change The Drug Industry
Forbes
Tuesday, June 29, 2010 - 9:07am
tags:
Avandia, GSK, diabetes
Lilly's Effient Tied in Study to Higher Rate of Cancer Risk Than Plavix
Bloomberg
Tuesday, June 29, 2010 - 9:05am
tags:
cancer, Effient, Eli Lilly, blood thinners, Plavix, Bristol-Myers Squibb
CSL Says Its Flu Vaccines Aren't Contaminated After U.S. FDA Issues Letter
Bloomberg
Tuesday, June 29, 2010 - 9:04am
tags:
FDA, CSL, Flu, vaccines, contamination
Teva Gets FDA OK for Generic Effexor XR
TheStreet.com
Tuesday, June 29, 2010 - 8:52am
tags:
Teva Pharmaceuticals, FDA, generics, Effexor XR, Pfizer, antidepressants
Eli Lilly: This Big Pharma Needs to Get Better
Seeking Alpha
Tuesday, June 29, 2010 - 8:51am
tags:
Eli Lilly, Pfizer, Sanofi, Bristol-Myers Squibb, Humalog, Zyprexa, Cymbalta, patents, Gemzar
Cholesterol drugs for the healthy still debatable
Yahoo/AP
Tuesday, June 29, 2010 - 8:49am
tags:
cholesterol, Crestor, statins, AstraZeneca
Forest Laboratories says potential diabetic pain drug Radiprodil fails midstage study
Yahoo/AP
Monday, June 28, 2010 - 7:03pm
tags:
Forest Labs, diabetes, clinical trials, Radiprodil
Is Eli Lilly a Buy?
Motley Fool
Monday, June 28, 2010 - 6:59pm
tags:
Eli Lilly
Merck Loses $8 Million Verdict in Trial Over Fosamax
Bloomberg Businessweek
Monday, June 28, 2010 - 3:05pm
tags:
Merck, Fosamax, osteoporosis, lawsuits
There Is Such a Thing as a Free Lunch, and Massachusetts Wants to Make It Law
BNET Pharma
Monday, June 28, 2010 - 3:01pm
tags:
physicians, physician gifts, Massachusetts
Dendreon’s Provenge Vaccine Faces Rationing
Pharmalot
Monday, June 28, 2010 - 3:00pm
tags:
Dendreon, Provenge, vaccines, prostate cancer
Amylin's New Diabetes Drug Well Tolerated By Sufferers
CNBC
Monday, June 28, 2010 - 2:59pm
tags:
Amylin, diabetes, Bydureon, type 2 diabetes
Exelixis: Finding Opportunity in a Bottomed Stock
Seeking Alpha
Monday, June 28, 2010 - 2:58pm
tags:
Exelixis, Bristol-Myers Squibb, cancer
The Sky's the Limit for Avanir Pharmaceuticals
Seeking Alpha
Monday, June 28, 2010 - 2:56pm
tags:
Avanir, Zenvia
Orexigen says obesity drug treated depression
Yahoo/AP
Monday, June 28, 2010 - 2:55pm
tags:
Orexigen, obesity, depression, Contrave
Biodel, Arena Pharma: Volume Movers
TheStreet.com
Monday, June 28, 2010 - 2:54pm
tags:
Biodel, Arena Pharmaceuticals, diabetes, obesity

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.